{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:58:37Z","timestamp":1772171917348,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005255","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T13:28:16Z","timestamp":1484227696000},"page":"e1005255","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-2264","authenticated-orcid":true,"given":"Luc E.","family":"Coffeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelus C.","family":"Hermsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sake J.","family":"de Vlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2015) World Malaria Report 2015."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria","volume":"183","author":"K Kester","year":"2001","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2007.05.005","article-title":"A phase I\/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S\/AS02A in malaria-na\u00efve adults","volume":"25","author":"K Kester","year":"2007","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"K Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1016\/j.vaccine.2014.06.033","article-title":"Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria na\u00efve adults","volume":"32","author":"K Kester","year":"2014","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","article-title":"Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data","volume":"13","author":"P Bejon","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref7","unstructured":"Joint Technical Expert Group on Malaria Vaccines (JTEG) and WHO Secretariat (2015) Background Paper on the Rts,S\/As01 Malaria Vaccine: 1\u201389."},{"key":"ref8","first-page":"33","article-title":"Malaria vaccine: WHO position paper\u2014January 2016","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-11-11","article-title":"A review of malaria vaccine clinical projects based on the WHO rainbow table","volume":"11","author":"L Schwartz","year":"2012","journal-title":"Malar J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"R Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1016\/j.vaccine.2009.07.049","article-title":"Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18\u201319 March 2009, Bethesda, MD, USA","volume":"27","author":"V Moorthy","year":"2009","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2012.12-0613","article-title":"Controlled human malaria infections by intradermal injection of cryopreserved <italic>Plasmodium falciparum<\/italic> sporozoites","volume":"88","author":"M Roestenberg","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e65960","DOI":"10.1371\/journal.pone.0065960","article-title":"Optimising Controlled Human Malaria Infection Studies Using Cryopreserved <italic>P<\/italic>. <italic>falciparum<\/italic> Parasites Administered by Needle and Syringe","volume":"8","author":"S Sheehy","year":"2013","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0166-6851(01)00379-6","article-title":"Detection of <italic>Plasmodium falciparum<\/italic> malaria parasites in vivo by real-time quantitative PCR","volume":"118","author":"C Hermsen","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.parint.2009.07.004","article-title":"The <italic>Plasmodium falciparum<\/italic> var gene transcription strategy at the onset of blood stage infection in a human volunteer","volume":"58","author":"C Wang","year":"2009","journal-title":"Parasitol Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"S Sheehy","year":"2012","journal-title":"Mol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2005.73.191","article-title":"Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials","volume":"73","author":"L Andrews","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/513990","article-title":"Clinical manifestations of <italic>Plasmodium falciparum<\/italic> malaria experimentally induced by mosquito challenge","volume":"175","author":"L Church","year":"1997","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e38434","DOI":"10.1371\/journal.pone.0038434","article-title":"Comparison of clinical and parasitological data from controlled human malaria infection trials","volume":"7","author":"M Roestenberg","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1473-3099(15)00068-7","article-title":"Design, recruitment, and microbiological considerations in human challenge studies","volume":"15","author":"T Darton","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4269\/ajtmh.2004.71.2.0700196","article-title":"Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction","volume":"71","author":"C Hermsen","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/427243","article-title":"Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites","volume":"191","author":"P Bejon","year":"2005","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/infdis\/jis355","article-title":"Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers","volume":"206","author":"M Roestenberg","year":"2012","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4269\/ajtmh.1997.57.495","article-title":"Measurement of <italic>Plasmodium falciparum<\/italic> growth rates in vivo: a test of malaria vaccines","volume":"57","author":"Q Cheng","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e5254","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A","volume":"4","author":"M Spring","year":"2009","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jit156","article-title":"Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection","volume":"208","author":"A Douglas","year":"2013","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/518510","article-title":"Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update","volume":"196","author":"J Epstein","year":"2007","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0031182001001202","article-title":"Population dynamics of untreated <italic>Plasmodium falciparum<\/italic> malaria within the adult human host during the expansion phase of the infection","volume":"124","author":"J Simpson","year":"2002","journal-title":"Parasitology"},{"key":"ref29","article-title":"Bayesian Approaches to Clinical Trials and Health-Care Evaluation","author":"D Spiegelhalter","year":"2004"},{"key":"ref30","first-page":"52","article-title":"Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes","volume":"63","author":"D Verhage","year":"2005","journal-title":"Neth J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","volume":"361","author":"M Roestenberg","year":"2009","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","article-title":"Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study","volume":"377","author":"M Roestenberg","year":"2011","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/jis725","article-title":"NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections","volume":"207","author":"A Teirlinck","year":"2013","journal-title":"J Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1073\/pnas.1220360110","article-title":"Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity","volume":"110","author":"E Bijker","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/infdis\/jiu354","article-title":"Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization","volume":"210","author":"W Nahrendorf","year":"2014","journal-title":"J Infect Dis"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T09:02:04Z","timestamp":1568710924000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005255"}},"subtitle":[],"editor":[{"given":"Neil M.","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005255","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727200918.793528865","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}